The global solar inverter market is set on a path of substantial growth, with forecasts predicting a robust Compound Annual ...

The biotech reported data from KOASTAL-1, the first of three phase 3 trials of navacaprant in major depressive disorder. Investigators randomized 383 people to receive the oral kappa opioid ...

(Image Credits: Pixabay) Novartis on Monday announced positive topline results from the Phase III STEER study ... patients with spinal muscular atrophy (SMA) Type 2. Efficacy and safety results ...

The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal onasemnogene abeparvovec (OAV101 IT) OAV101 IT ...

The Phase III STEER study met its ... HFMSE is a gold standard for SMA-specific assessment of motor ability and disease progression. 2,3, 4,5,6 The increase was observed in patients treated ...

Basel, [December 30, 2024] – Novartis today announced positive topline results from the Phase III STEER study ... with spinal muscular atrophy (SMA) Type 2, aged two to less than 18 years ...

Winning one Super Bowl is tough. Winning two? That’s legendary. But what about making it to three in a row? That’s a feat reserved for a select few teams in NFL history. With the Kansas City ...

College of Materials, Institute of Artificial Intelligence, State Key Laboratory of Physical Chemistry of Solid Surfaces, College of Chemistry and Chemical Engineering, iChEM, Fujian Key Laboratory of ...